Bionano Genomics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Bionano Genomics, Inc. (BNGO) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-10
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$550.00K.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.42M.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $522.00K.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $721.00K, a 85.82% increase year-over-year.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$580.00K.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$2.24M.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$2.52M, a 789.07% decline from fiscal 2022.
- Bionano Genomics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $366.00K, a 90.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.97M 10-Q · filed 2026-08-10 | -$1.45M derived: sum of 3 quarters · filed 2026-08-10 | -$724.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$1.42M 10-Q · filed 2026-05-13 | -$895.00K derived: sum of 2 quarters · filed 2026-05-13 | -$174.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.51M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.24M derived: sum of 2 quarters · filed 2026-03-23 | -$92.00K derived: sum of 3 quarters · filed 2026-08-10 | -$580.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $721.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$614.00K derived: sum of 2 quarters · filed 2026-08-10 | -$1.10M 10-Q · filed 2025-11-13 | -$1.65M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.82M 10-Q · filed 2026-08-10 | -$2.37M derived: sum of 3 quarters · filed 2026-08-10 | -$1.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$488.00K 10-Q · filed 2026-05-13 | -$1.03M derived: sum of 2 quarters · filed 2026-05-13 | -$646.00K derived: sum of 3 quarters · filed 2026-05-13 | -$5.90M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$158.00K derived: sum of 2 quarters · filed 2026-03-23 | -$5.41M derived: sum of 3 quarters · filed 2026-03-23 | -$2.24M 10-K · filed 2026-03-23 | -$1.99M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$4.86M derived: sum of 2 quarters · filed 2025-11-13 | -$1.69M 10-Q · filed 2025-11-13 | -$1.69M 10-Q · filed 2024-11-14 | -$5.18M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.08M 10-Q · filed 2025-08-14 | -$5.57M derived: sum of 3 quarters · filed 2025-08-14 | -$2.53M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $3.17M 10-Q · filed 2025-05-14 | -$315.00K derived: sum of 2 quarters · filed 2025-05-14 | $2.72M derived: sum of 3 quarters · filed 2025-05-14 | $1.63M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$453.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.54M derived: sum of 3 quarters · filed 2025-03-31 | -$2.52M 10-K · filed 2025-03-31 | -$2.52M 10-K · filed 2024-03-05 | |||
| 2023-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.95M derived: sum of 2 quarters · filed 2024-11-14 | $967.00K 10-Q · filed 2024-11-14 | -$734.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.07M 10-Q · filed 2024-08-07 | -$3.77M derived: sum of 3 quarters · filed 2024-08-07 | -$226.00K derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$978.00K 10-Q · filed 2024-05-08 | -$2.68M derived: sum of 2 quarters · filed 2024-05-08 | $865.00K derived: sum of 3 quarters · filed 2024-05-08 | -$169.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.84M derived: sum of 2 quarters · filed 2024-03-05 | $809.00K derived: sum of 3 quarters · filed 2024-03-05 | $366.00K 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.51M derived: sum of 2 quarters · filed 2023-11-08 | $2.07M 10-Q · filed 2023-11-08 | $1.92M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.48M 10-Q · filed 2023-08-09 | -$1.62M derived: sum of 3 quarters · filed 2023-08-09 | $1.40M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$443.00K 10-Q · filed 2023-05-09 | -$588.00K derived: sum of 2 quarters · filed 2023-05-09 | $2.43M derived: sum of 3 quarters · filed 2023-05-09 | $4.56M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.87M derived: sum of 2 quarters · filed 2023-03-09 | $5.00M derived: sum of 3 quarters · filed 2023-03-09 | $3.96M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.15M derived: sum of 2 quarters · filed 2022-11-03 | $4.10M 10-Q · filed 2022-11-03 | $5.17M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.08M 10-Q · filed 2022-08-04 | $2.16M derived: sum of 3 quarters · filed 2022-08-04 | $3.57M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$1.04M 10-Q · filed 2022-05-05 | $27.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.45M derived: sum of 3 quarters · filed 2022-05-05 | $1.08M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.49M derived: sum of 2 quarters · filed 2022-03-01 | $2.12M derived: sum of 3 quarters · filed 2022-03-01 | $1.48M 10-K · filed 2022-03-01 | $1.48M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.05M derived: sum of 2 quarters · filed 2021-11-04 | $412.00K 10-Q · filed 2021-11-04 | $1.09K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$1.01M 10-Q · filed 2021-08-04 | -$1.42M derived: sum of 3 quarters · filed 2021-08-04 | -$711.91K derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$639.00K 10-Q · filed 2021-05-13 | -$1.05M derived: sum of 2 quarters · filed 2021-05-13 | -$344.91K derived: sum of 3 quarters · filed 2021-05-13 | -$1.26M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$410.91K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $294.09K derived: sum of 2 quarters · filed 2021-03-23 | -$624.91K derived: sum of 3 quarters · filed 2021-03-23 | -$73.91K 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | $705.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$214.00K derived: sum of 2 quarters · filed 2020-11-13 | $337.00K 10-Q · filed 2020-11-13 | $337.14K 10-Q · filed 2019-11-07 | -$16.88K derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | -$919.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$368.00K 10-Q · filed 2020-08-13 | -$367.63K 10-Q · filed 2019-08-08 | -$721.88K derived: sum of 3 quarters · filed 2020-08-13 | -$664.76K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $551.00K 10-Q · filed 2020-06-18 | $550.51K 10-Q · filed 2019-05-09 | $197.12K derived: sum of 2 quarters · filed 2020-06-18 | $254.24K derived: sum of 3 quarters · filed 2020-06-18 | $1.22M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$353.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$296.76K derived: sum of 2 quarters · filed 2020-03-10 | $673.39K derived: sum of 3 quarters · filed 2020-03-10 | -$247.40K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $57.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.03M derived: sum of 2 quarters · filed 2019-11-07 | $106.48K 10-Q · filed 2019-11-07 | $501.55K derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $970.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $49.36K 10-Q · filed 2019-08-08 | $444.43K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | -$920.79K 10-Q · filed 2019-05-09 | -$525.72K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | $395.07K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$123.23K 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | -$518.30K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |